Food and Drug Regulations, C.R.C., c. 870

Section C.02.012

Cite as Food and Drug Regulations, C.R.C., c. 870, s. C.02.012 · current to June 17, 2026 · regulation last amended June 17, 2026

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) Every fabricator, packager/labeller, distributor referred to in section C.01A.003, importer and wholesaler of a drug shall maintain (a) a system of control that permits complete and rapid recall of any lot or batch of the drug that is on the market; and (b) a program of self-inspection. (2) Every fabricator and packager/labeller and, subject to subsections (3) and (4), every distributor referred to in paragraph C.01A.003(b) and importer of a drug shall maintain a system to ensure that any lot or batch of the drug fabricated and packaged/labelled on premises other than their own is fabricated and packaged/labelled in accordance with the requirements of this Division. (3) Subsection (2) does not apply to a distributor if the drug is fabricated, packaged/labelled and tested in Canada by a person who holds an establishment licence that authorizes those activities in respect of that drug. (4) Subsection (2) does not apply to a distributor or importer if the drug is fabricated or packaged/labelled in an MRA country at a recognized building and both of the following requirements are met: (a) the address of the building is set out in their establishment licence; and (b) they retain a copy of the batch certificate for each lot or batch of the drug that they receive.
Read the Food and Drug Regulations on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.